Journal article
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
Abstract
Our objective was to evaluate the toxicity of the anti-CD33 monoclonal antibody HuM195 modified with peptides (CGYGPKKKRKVGG) harboring the nuclear localizing sequence (NLS; underlined) of simian virus 40 large T antigen and labeled with (111)In against acute myeloid leukemia (AML) cells.
METHODS: HuM195 was derivatized with sulfosuccinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate (sulfo-SMCC) to introduce maleimide groups for reaction …
Authors
Chen P; Wang J; Hope K; Jin L; Dick J; Cameron R; Brandwein J; Minden M; Reilly RM
Journal
Journal of Nuclear Medicine, Vol. 47, No. 5, pp. 827–836
Publication Date
May 2006
ISSN
0161-5505
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Active Transport, Cell NucleusAntibodies, MonoclonalAntigens, CDAntigens, Differentiation, MyelomonocyticCell ProliferationCell SurvivalHL-60 CellsHumansIndium RadioisotopesK562 CellsLeukemia, MyeloidNuclear Localization SignalsPeptidesRadionuclide ImagingSialic Acid Binding Ig-like Lectin 3U937 Cells